BOT:ASX
Botanix Pharmaceuticals Ltd
A$ 0.010
0.00%
(0.00) Siku 1
10 Nov, 10:15:48 GMT +11 · AUD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya BOT...
Fungua
A$ 0.01
Juu
A$ 0.01
Chini
A$ 0.01
Mtaji wa soko
27.63M
Wastani wa kiasi cha mauzo
10.01M
Kiasi cha mauzo ya hisa
2.51M
Juu kwa wiki 52
A$ 0.15
Chini kwa wiki 52
A$ 0.01
EPS
-A$ 0.03
Hisa za wawekezaji
2.76B
Idadi ya wafanyakazi
11
Fungua
A$ 0.01
Juu
A$ 0.01
Chini
A$ 0.01
Mtaji wa soko
27.63M
Wastani wa kiasi cha mauzo
10.01M
Kiasi cha mauzo ya hisa
2.51M
Juu kwa wiki 52
A$ 0.15
Chini kwa wiki 52
A$ 0.01
EPS
-A$ 0.03
Hisa za wawekezaji
2.76B
Idadi ya wafanyakazi
11
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
WGN Radio 720
·
dakika 31 zilizopita
Terry Savage: Good news regarding the Dow
Quantisnow
·
dakika 21 zilizopita
Autoliv Declares Increased Quarterly Dividend
RealMoney Pro
·
dakika 58 zilizopita
A Look at Monday’s Charts
Bloomberg.com
·
saa 1 iliyopita
Asian Stocks to Rally on US Tech Surge, Oil Slump: Markets Wrap
Wasifu
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
Kuhusu Botanix Pharmaceuticals Ltd
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi11
Lilianzishwa1984
Makao makuu-
SektaHealth Care
Sekta-
Tovutibotanixpharma.com